Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

MITO

Stealth BioTherapeutics (MITO)

Stealth BioTherapeutics Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MITO
DateTimeSourceHeadlineSymbolCompany
29/11/202210:41Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:MITOStealth BioTherapeutics Corporation
17/11/202208:23Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MITOStealth BioTherapeutics Corporation
17/11/202208:22Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MITOStealth BioTherapeutics Corporation
17/11/202208:20Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MITOStealth BioTherapeutics Corporation
17/11/202208:19Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MITOStealth BioTherapeutics Corporation
17/11/202208:16Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:MITOStealth BioTherapeutics Corporation
17/11/202208:14Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:MITOStealth BioTherapeutics Corporation
17/11/202208:10Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MITOStealth BioTherapeutics Corporation
17/11/202208:08Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:MITOStealth BioTherapeutics Corporation
17/11/202208:01PR Newswire (US)Stealth BioTherapeutics Corp Announces Completion of MergerNASDAQ:MITOStealth BioTherapeutics Corporation
01/11/202222:30PR Newswire (US)Stealth BioTherapeutics Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)NASDAQ:MITOStealth BioTherapeutics Corporation
08/10/202207:01PR Newswire (US)Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of ShareholdersNASDAQ:MITOStealth BioTherapeutics Corporation
01/10/202207:01TipRanksStealth Biotherapeutics announces resignation of CFO Robert WeiskopfNASDAQ:MITOStealth BioTherapeutics Corporation
01/10/202207:00PR Newswire (US)Stealth BioTherapeutics Announces Departure of Chief Financial OfficerNASDAQ:MITOStealth BioTherapeutics Corporation
24/09/202207:21Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MITOStealth BioTherapeutics Corporation
16/09/202206:45PR Newswire (US)Stealth BioTherapeutics to Participate in Upcoming Ultra-Rare Disease EventsNASDAQ:MITOStealth BioTherapeutics Corporation
20/08/202206:16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MITOStealth BioTherapeutics Corporation
19/08/202223:50Edgar (US Regulatory)Statement of Ownership: Private Transaction (sc 13e3)NASDAQ:MITOStealth BioTherapeutics Corporation
02/08/202206:46Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MITOStealth BioTherapeutics Corporation
01/08/202223:48Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MITOStealth BioTherapeutics Corporation
01/08/202222:30PR Newswire (US)Stealth BioTherapeutics Corp Enters Definitive Agreement for Going Private TransactionNASDAQ:MITOStealth BioTherapeutics Corporation
12/07/202207:21Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MITOStealth BioTherapeutics Corporation
12/07/202207:15PR Newswire (US)STEALTH BIOTHERAPEUTICS ANNOUNCES RECEIPT OF NON-COMPLIANCE NOTICE FROM NASDAQNASDAQ:MITOStealth BioTherapeutics Corporation
28/06/202206:50Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MITOStealth BioTherapeutics Corporation
28/06/202200:25AllPennyStocks.comPremarket Indicating Higher Open For This BiotechNASDAQ:MITOStealth BioTherapeutics Corporation
27/06/202222:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MITOStealth BioTherapeutics Corporation
27/06/202221:30PR Newswire (US)Stealth BioTherapeutics Corp Announces Receipt of Preliminary Non-Binding ProposalNASDAQ:MITOStealth BioTherapeutics Corporation
16/06/202220:15TipRanksH.C. Wainwright Thinks Stealth Biotherapeutics’ Stock is Going to RecoverNASDAQ:MITOStealth BioTherapeutics Corporation
16/06/202220:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:MITOStealth BioTherapeutics Corporation
14/06/202221:25PR Newswire (US)Stealth BioTherapeutics Granted Pre-NDA Meeting for Elamipretide as a Potential Treatment for Barth SyndromeNASDAQ:MITOStealth BioTherapeutics Corporation
 Showing the most relevant articles for your search:NASDAQ:MITO